View Older Stories View More Recent Stories

Sep 7, 2022 04:55PM Veracyte (VCYT) Says New Data Suggest Envisia Genomic Classifier Can Help Predict Disease Progression in Interstitial Lung Disease Patients
Sep 7, 2022 04:54PM New Data Suggest Veracyte’s Envisia Genomic Classifier Can Help Predict Disease Progression in Interstitial Lung Disease Patients Treated with Combination Immunosuppressive Therapy
Sep 1, 2022 05:00PM Veracyte to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
Aug 31, 2022 07:00AM Veracyte Announces Seven Abstracts to Be Presented at ESMO Congress 2022
Aug 29, 2022 11:19AM New Data in Nature Medicine Suggest Pre-Treatment Tumor Microenvironment Can Impact Response for CAR T-Cell Therapy in Patients with Large B-Cell Lymphoma
Aug 11, 2022 04:11PM Veracyte (VCYT) Appoints Eliav Barr to its Board
Aug 11, 2022 04:05PM Veracyte Appoints Eliav Barr, M.D., to Its Board of Directors
Aug 2, 2022 04:05PM Veracyte Announces Second Quarter 2022 Financial Results
Jul 20, 2022 04:16PM Veracyte (VCYT) Reports Clinical Validation Data for RNA Sequencing-Based Afirma Medullary Thyroid Cancer Classifier Published in Thyroid
Jul 20, 2022 04:15PM Veracyte Announces New Clinical Validation Data for RNA Sequencing-Based Afirma Medullary Thyroid Cancer Classifier Published in Thyroid
Jul 14, 2022 04:30PM Veracyte to Release Second Quarter 2022 Financial Results on August 2, 2022
Jul 13, 2022 04:16PM Veracyte (VCYT) Announces Publication of Data Validating Clinical Performance of Veracyte’s Percepta Genomic Sequencing Classifier in Lung Cancer Diagnosis
Jul 13, 2022 04:15PM New Data Published in PLOS ONE Validate the Clinical Performance of Veracyte’s Percepta Genomic Sequencing Classifier in Lung Cancer Diagnosis
Jun 27, 2022 08:15AM Veracyte Named a San Francisco “Bay Area Top Workplace” For Ninth Consecutive Year
Jun 20, 2022 08:15AM New Data Show Strong Performance of Veracyte’s Afirma GSC in Real-World Clinical Practice
Jun 3, 2022 08:32AM Veracyte (VCYT) Reports Publication Reinforcing Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier
Jun 3, 2022 08:30AM Data Published in Annals of Oncology Reinforce Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier for Informing Treatment of Men Experiencing Prostate Cancer Progression
May 31, 2022 04:20PM Veracyte (VCYT) Announces New Data Show Immunoscore IC Assay May Predict Patients Likely to Benefit from Addition of Immunotherapy to Standard First-Line Therapy for Metastatic Colorectal Cancer
May 31, 2022 04:20PM Veracyte Announces that New Data Show Immunoscore IC Assay May Predict Patients Likely to Benefit from Addition of Immunotherapy to Standard First-Line Therapy for Metastatic Colorectal Cancer
May 26, 2022 05:10PM  New Data to be Shared at ASCO 2022 Underscore Clinical Utility of Decipher Prostate Genomic Classifier
May 26, 2022 05:07PM Veracyte (VCYT) Announces New Data to be Presented at ASCO 2022 Showing Immunoscore IC Assay’s Ability to Identify Patients with NSCLC Who May Benefit from Immune Checkpoint Inhibitors
May 26, 2022 05:05PM Veracyte Announces New Data to be Presented at ASCO 2022 Showing Immunoscore IC Assay’s Ability to Identify Patients with NSCLC Who May Benefit from Immune Checkpoint Inhibitors
May 26, 2022 08:15AM Veracyte to Present at Upcoming Investor Conferences
May 16, 2022 04:19PM Veracyte (VCYT) Announces New Data Reinforcing Percepta Nasal Swab Test’s Clinical Performance and Utility in Lung Cancer Risk Assessment
May 16, 2022 04:17PM Veracyte Announces New Data Reinforcing Percepta Nasal Swab Test’s Clinical Performance and Utility in Lung Cancer Risk Assessment
May 12, 2022 04:36PM Updated AUA/ASTRO Guideline Includes Supportive Statement for Use of Genomic Tests, Including Decipher Prostate, for Men With Localized Prostate Cancer
May 12, 2022 08:30AM Veracyte Announces that Data for Its Genomic and Immuno-Oncology Offerings Will Be Highlighted at the 2022 ASCO Annual Meeting
May 4, 2022 08:30AM Veracyte Announces New Consensus Data from PROCURE Study Presented at ESMO Breast Cancer 2022
May 3, 2022 04:05PM Veracyte Announces First Quarter 2022 Financial Results
May 2, 2022 04:18PM Envisia Genomic Classifier Highlighted in Updated Clinical Practice Guideline Regarding Idiopathic Pulmonary Fibrosis Diagnosis
May 2, 2022 04:01PM Intellia Therapeutics Names Muna Bhanji, R.Ph., to its Board of Directors
Apr 28, 2022 04:15PM Veracyte Announces New Urologic Cancer Data To Be Presented at AUA 2022 International Conference
Apr 26, 2022 04:05PM Veracyte Announces New Performance Data for the Percepta Nasal Swab Test To Be Presented at ATS 2022 International Conference
Apr 19, 2022 08:15AM Veracyte to Release First Quarter 2022 Financial Results on May 3, 2022
Mar 1, 2022 04:05PM Veracyte to Participate in the Cowen 42nd Annual Health Care Conference
Feb 28, 2022 04:05PM Veracyte Announces Fourth Quarter and Full-Year 2021 Financial Results
Feb 28, 2022 08:30AM Veracyte Appoints Annie McGuire as General Counsel
Feb 22, 2022 08:30AM Veracyte Appoints Jonathan Wygant as Chief Accounting Officer
Feb 15, 2022 08:30AM Veracyte to Release Fourth Quarter and Full-Year 2021 Financial Results on February 28, 2022
Feb 14, 2022 07:30PM New Data Validate Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier To Help Guide Therapy In Men with Intermediate-Risk Prostate Cancer
Feb 8, 2022 04:05PM Veracyte to Participate in 11th Annual SVB Leerink Global Healthcare Conference
Jan 31, 2022 08:25AM Veracyte Announces New Data to be Presented at the 2022 ASCO Genitourinary (GU) Cancers Symposium
Jan 24, 2022 08:31AM Veracyte (VCYT) Announces New Data Suggest Percepta Genomic Sequencing Classifier Can Help Accelerate Timely Treatment for Patients with Early-Stage Lung Cancer
Jan 24, 2022 08:30AM New Data Suggest Veracyte’s Percepta Genomic Sequencing Classifier Can Help Accelerate Timely Treatment for Patients with Early-Stage Lung Cancer
Jan 6, 2022 08:32AM Veracyte (VCYT) Announces Key Leadership Promotions to Advance Its Strategic Global Vision
Jan 6, 2022 08:30AM Veracyte Announces Key Leadership Promotions to Advance Its Strategic Global Vision
Dec 14, 2021 04:05PM Veracyte Announces Publication of Data Demonstrating Clinical Utility of Its Envisia Genomic Classifier to Improve IPF Diagnosis
Nov 24, 2021 05:48AM Veracyte (VCYT) Announces Further Reimbursement Expansion for Prosigna Breast Cancer Test in Europe
Nov 24, 2021 04:32AM Veracyte Announces Further European Reimbursement Expansion for Prosigna Breast Cancer Test
Nov 13, 2021 07:00AM Veracyte Announces New Data on Immuno-Oncology Offerings Presented at SITC 2021
View More Recent Stories View Older Stories